pression of TNF-␣ in endothelial cells increased angiogenic sprout formation in the presence but also in the absence of angiogenic growth factors. The partial neutralization of this effect by TNF-␣ antibodies and the inability of conditioned media from stable TNF-␣ -expressing endothelial cells to induce angiogenic activities in control endothelial cells suggest that this effect does not require expression of additional autocrine factors, but is an autonomous effect of the transmembrane TNF on the endothelial cells. Furthermore, using the Matrigel plug assay in vivo, increased angiogenesis was observed in endothelial TNF-␣ -expressing transgenic versus control mice. In conclusion, chronic infl ammatory changes mediated by TNF-␣ can induce angiogenesis in vitro and in vivo, suggesting endothelial cell activation as a direct link between infl ammation and angiogenesis. 
Introduction
Endothelial cell activation is essential for many vascular pathologic processes, leading to infl ammation, vascular remodeling, and vessel growth. In diseases associated with chronic infl ammation, such as atherosclerosis, endothelial activation plays a role in both initiation and prolongation and exacerbation of the pathology. Such chronic endothelial activation is accompanied by endothelial dysfunction, characterized by sustained expression of leukocyte adhesion molecules, and thus, sustained leukocyte involvement, vascular permeability, dysregulation of vasoreactivity, a thrombogenic propensity, abnormal blood vessel remodeling, and, last but not least, angiogenesis [1] . Angiogenesis, the process of new blood vessel formation, is essential for embryonic growth, wound healing, the female reproductive cycle, and pregnancy in physiological settings [2, 3] . In contrast, excessive angiogenesis is noted in tumors, rheumatoid arthritis, atherosclerosis, psoriasis, obesity, infl ammatory bowel disease, primary pulmonary hypertension, diabetic retinopathy, asthma, and advanced macular degeneration of the eye [3, 4] .
The fi nding that infl ammation is often associated with increased angiogenesis was explained by infl ammationinduced production of angiogenic factors, either from vascular or other tissue cells, or from infi ltrating leukocytes. Proinfl ammatory mediators, such as tumor necrosis factor-␣ (TNF-␣ ), are known to activate the endothelium and increase expression of adhesion molecules and chemokines, which are critical steps for leukocyte recruitment [1] . These recruited leukocytes can mediate angiogenesis by release of endothelial growth factors [5] [6] [7] . However, there is insuffi cient experimental study of the precise mechanisms in chronic situations and it is unknown to what extent leukocyte-independent mechanisms also contribute to the angiogenesis. For instance, acute endothelial cell activation by TNF-␣ can elicit diverse effects dependent upon the state of the cells and other factors present. An anti-angiogenic role of TNF-␣ was suggested by the ability of soluble TNF-␣ receptor antibodies to increase endothelial cell proliferation [8] . In contrast, stimulation of angiogenesis by TNF was observed in the presence of either vascular endothelial growth factor (VEGF) or basic fi broblast growth factor (bFGF) [9] , which was suggested to be mediated by activation of urokinase-type plasminogen activator. However, the role of TNF or other proinfl ammatory molecules in directly infl uencing angiogenesis in chronic diseases is not known, despite the fact that TNF-␣ and the TNF-␣ receptor superfamily are strongly implicated in a number of chronic diseases [10] [11] [12] [13] [14] .
TNF-␣ , the founding member of the TNF family of cytokines, is produced as a transmembrane spanning precursor protein (tmTNF-␣ ) and a proteolytically cleaved soluble form. Given the correlation of soluble TNF-␣ concentration in plasma with infectious and infl ammatory diseases, it is understandable that this form was soon perceived as the natural form of TNF-␣ , while the transmembrane form being present or induced on a variety of immune and non-immune cells (including endothelial cells) was widely disregarded. However, more recently, a variety of conditions that activate endothelial cells have been convincingly shown to express tmTNF-␣ in vitro and in vivo [15] [16] [17] [18] [19] [20] [21] [22] . Despite the exponential awareness of the critical role for endothelial activation in many diseases, there is a dearth of models to study the initiating disease potential and direct effects of continuous endothelial activation. In order to mimic the situation of chronic activated endothelium, we have established models of stable TNF-␣ expression in endothelial cells in vitro and in transgenic mice in vivo using an uncleavable mutant of TNF-␣ .
Using these specifi c models, we demonstrated an increase in cell adhesion molecules and reactive oxygen species (ROS) as a measure of continuous activated endothelium, a signifi cant increase in sprout formation as a measure of in vitro angiogenesis, and increased neovascularization in Matrigel plugs as a measure of in vivo angiogenesis. Thus, in this study, we show that angiogenesis could be induced per se by activated endothelium, establishing a direct link between infl ammation and angiogenesis.
Generation of tmTNF-␣ -Expressing Endothelial Cells
Polyoma virus middle T-transformed endothelial cells from wild-type newborn mice were kindly provided by F. Kiefer (Mün-ster, Germany) [25] and cultured in DMEM supplemented with 10% FCS, 2 m M glutamine, and 1 ! penicillin/streptomycin. Cells were transfected with the uncleavable transmembrane mutant form of murine TNF-␣ [mTNF ␣⌬ 1-9,K(11)E] [26] by retroviral gene transfer. The cDNA for mTNF ␣⌬ 1-9,K(11)E [27] was cloned into the pBABE/neo vector [28] and stably transfected into the retrovirus packaging cell line GP+E86 [29] . Culture supernatants of transfected GP+E86 cells supplemented with 8 g/ml polybrene were used for infection of endothelial cells for 3 h. Infected endothelial cells were selected with gentamycin-containing medium (1 mg/ml). Endothelial cells transfected with the empty vector were treated identically and used as control cells.
Flow Cytometric Analysis of Cell Adhesion Molecules
Cytofl uorometric analysis (FACS) was performed as previously described [18] . Both control and tmTNF-␣ -expressing endothelial cells were cultured to confl uency, detached using EDTA buffer, and incubated with primary antibodies -hybridoma supernatant immunoglobulin G (IgG) in phosphate buffer supplemented with 2.5% FCS and 0.02% sodium azide -for 30 min at 4 ° C. After washing, cells were incubated with phycoerythrin-conjugated secondary antibody (Dianova, Hamburg, Germany) and analyzed on a FACStar using CellQuest software (Becton Dickinson, Heidelberg, Germany) drawing light scatter gates around live endothelial cell populations.
Real-Time Analysis of Intracellular ROS Production
H2DCFDA is a commonly used dye that allows the monitoring of intracellular ROS production in general, regardless of the precise enzymatic or non-enzymatic source, as it is oxidized by a number of oxidant species, including nitric oxide (NO) [30] . This method is based on the uptake and intracellular hydrolysis of the H2DCFDA dye by intracellular esterases to the non-fl uorescent derivative, DCFH, which is polar and trapped within the cells. Confl uent endothelial cells in 96-well black-walled plates were incubated in DMEM and 10 M H2DCFDA for 30 min to allow intracellular uptake. Cells were washed 3 times and media replaced (without dye but with 1% albumin). Fluorescence of the oxidized dye was subsequently determined at 495 nm (excitation), 525 nm (emission), with 515 nm cutoff on a Flex station set for maximal detection in monolayer cells compared with dye alone. Non-specifi c background fl uorescence (no dye) was not different between groups (different cell treatments or different inhibitor additions) and was subtracted to give specifi c relative fl uorescence units. In order to verify that the oxidation of DCFH was dependent on ROS production, an inhibition dose response to the radical scavenger, Trolox, was determined with an inhibitor present throughout dye loading, washing, and the subsequent assay. As DCFH oxidation responds to NO as well [31] , we also examined the inhibition in the presence of the NO synthase inhibitor, N G -nitro-L -arginine methyl esther ( L -NAME). To assess the relative contribution of NAPDH oxidase to ROS formation, we analyzed the oxidation of DHE to ethidium, which is more specifi c for superoxide, in the presence and absence of several concentrations of the NAPDH oxidase inhibitor, apocynin. Cells were loaded 30 min with 5 M DHE, washed, and media replaced as for DCFH. Ethidium oxidization was determined on the Flex Station at 520 nm (excitation), 605 nm (emission), with 595 nm cutoff.
In vitro Sprout Formation Assay
Angiogenesis in vitro was tested as described previously, with slight modifi cations [32] . Briefl y, the endothelial cells were grown to confl uence on cytodex-3 microcarrier beads (Sigma) and placed into a 12-well culture plate (Nalge Nunc Int., Rochester, N.Y., USA) containing fi brinogen gel. Polymerization was started by adding 0.48 U/ml thrombin. About 1 ml of the media with or without factors of interest was added to each well and incubated for 1 h at 37 ° C, 5% CO 2 . After 1 h, the media was replaced with fresh media with the respective factors and incubation was continued. After 24 h, the gel was fi xed in 1% paraformaldehyde and the number of sprouts per 50 beads longer than the average bead size was counted under a phase contrast microscope. No signifi cant morphological differences were noted between controls and tmTNF cell sprouts. Experiments were performed in triplicate and repeated at least four times. For inter-individual observational differences, the number of sprouts was also counted by a person blinded to the study design.
Tie2-tmTNF Transgenic Animals
The construction of transgene and the generation of Tie2-tmTNF transgenic animals were described previously [27] . These mice contain the cDNA of the uncleavable mTNF ␣⌬ 1-9,K(11)E cloned between endothelial-specifi c Tie2 promoter and the Tie2 fi rst intron in order to localize TNF-␣ specifi c to the endothelium.
Mice used for this study had been back-crossed for more than eight generations in C57BL/6 animals. Mice were used as heterozygous for the transgene, and non-transgenic litter mates served as wildtype controls.
Angiogenesis in vivo/Matrigel Plug Assay
A modifi ed method of the Matrigel plug assay described by Passaniti et al. [33] was used to assess angiogenesis in Tie2-tmTNF transgenic mice and non-transgenic littermates. Briefl y, Matrigel was mixed with 200 ng/ml bFGF and 500 ng/ml VEGF 165 , and 0.4 ml were subcutaneously injected into mice. After 14 days, Matrigel plugs were harvested, fi xed in 1% paraformaldehyde for 4.5 h on ice, and embedded in paraffi n. After deparaffi nation, alternate 6-m sections from the center of the excised Matrigel plugs were stained with rat monoclonal antibodies to CD31 and CD34. Sections were developed after incubation with a biotin-conjugated goat anti-rat IgG secondary antibody (Dianova, 1: 100) using the vectastain Elite ABC Kit (Vector Laboratories, Burlingame, Calif., USA) and the AEC Chromogen Kit (Sigma) according to the manufacturers' instructions. Stained cells were counted in several sections and high-power fi elds (at least 20/animal), and the amounts of CD31-or CD34-positive cells were calculated.
Statistical Analysis
Data are expressed as mean 8 SD for each group, performed in triplicate for in vitro sprout assay and for the measurement of ROS production. Statistical signifi cance was determined by ANO-VA using the Microsoft Excel Statistical Package and by Welch's t test using InStat software for the in vivo Matrigel plug assay. A probability value p ! 0.05 was considered statistically signifi cant.
Results

tmTNF-␣ Overexpression in Endothelial Cells Leads to Continuous Expression of Intercellular Adhesion Molecules
We have previously reported that transfection of immortalized macrovascular human umbilical cord vein endothelial cells with a transmembrane uncleavable mutant form of TNF-␣ leads to continuous activation of proinfl ammatory signal transduction pathways (p38 mitogenactivated protein kinase and nuclear factor-B) and tissue factor production [18] . Here, we stably transfected polyoma middle T immortalized murine endothelial cells, which are of microvascular appearance, with the trans- 
Increased ROS Concentrations in Endothelial Cells
Expressing tmTNF-␣ Another hallmark of activated endothelium in chronic infl ammation is the increased production of free ROS.
Soluble TNF-␣ is known to induce the formation of ROS, which results from NADPH oxidase activation, but also induces increased expression of specifi c members of the NADPH oxidase complex, such as the gp91 phox [34] . Based on our fi ndings from gene expression studies in tmTNF-␣ -expressing endothelial cells (unpublished data) that this subunit (NOX2 isoform) is increased 7-fold, we reasoned that these cells may show continuously increased ROS levels. When assessing intracellular ROS concentrations by oxidation of DCFH (a fl uorescent substrate), we found increased concentrations in tmTNF-␣ -expressing versus control endothelial cells, which was attenuated by the addition of the antioxidant Trolox ( fi g. 2 a, b). As seen in the Trolox dose-response curve ( fi g. 2 a), this inhibition is maximally 65%, whereas higher levels of Trolox can actually increase the oxidant load and increase DCFH oxidation. This pro-oxidant effect at a higher concentration of anti-oxidants, such as vitamin E, is well documented [35] . Notably, addition of the NO synthase inhibitor, L -NAME, further reduced DCFH oxidation (combined average inhibition of 97%) indicating that NO-mediated dye oxidation accounted for the remainder of the DCFH fl uorescence which was not inhibited by Trolox alone ( fi g. 2 a). Next, we assessed the potential contribution of NADPH oxidase-derived superoxide to ROS accumulation in the tmTNF-␣ cells by analyzing apocynin-induced inhibition of ethidium oxidation, a more specifi c marker for superoxide generation [36] . Similar to the chronic increase in ROS production in general, as detected by DCFH oxidation, tmTNF-␣ expression significantly increased ethidium oxidation ( fi g. 2 c). Apocynin only very modestly reduced the ethidium oxidation in control cells, indicating that most superoxide radicals were derived from other sources, such as the mitochondrial respiration, under basal condition in control cells.
However, in the tmTNF-␣ cells, apocynin reversed 70% of the gain over control. This indicates that chronic activation of NADPH oxidase in the tmTNF cells importantly contributed to the increased oxidant load. In conclusion, stable tmTNF-␣ expression leads to persistent activation in endothelial cells, which resembles a dysfunctional and proinfl ammatory phenotype.
Enhanced Sprout Formation (Angiogenesis) in tmTNF-␣ Endothelial Cells
Microvascular endothelial cells are believed to initiate sprouting angiogenesis, which is observed to be increased in chronic infl ammatory diseases. In order to test the hypothesis that endothelial activation induces angiogenic activity, we assessed tmTNF-␣ -expressing endothelial cells in an in vitro assay for angiogenesis. Endothelial cells grown on microcarrier beads were embedded into a fi brin gel in the presence or absence of VEGF to induce sprouting. Randomly 50 individual beads with sprouts longer than the average size of beads were counted in the pres- thelial cells demonstrated a signifi cant (p ! 0.05) increase in capillary-like sprouts as compared with control clones ( fi g. 3 ). This effect was comparable with the effects of VEGF alone on control cells, indicating that these cells become independent from requirement for exogenous growth factor-induced angiogenesis, although growth factor addition caused a further, additive increase in angiogenesis in vitro ( fi g. 3 ).
The Angiogenic Effect of Stable tmTNF-␣ Expression
Is Direct
To further explore whether this angiogenic effect of stable tmTNF expression is due to the release of growth factors or to a direct effect on endothelial signaling, we have performed experiments quantifying the effect of conditioned media (CM) on endothelial sprouting ( fi g. 4 ). Both control and tmTNF cells were seeded in T75 fl asks supplemented with VEGF and FGF, were injected subcutaneously under the skin of 8-week-old animals. Matrigel plugs were excised after 2 weeks from 8 Tie2-tmTNF transgenic and 6 wild-type animals and embedded into paraffi n. a , b Sections, stained with anti-CD34 antibodies, from wild-type (wt) and transgenic (Tie2-tmTNF) animals. Whereas in control animals only very few CD34-positive cells in vessel-like structures were found ( a ; arrows), in sections from Tie2-tmTNF mice, many vessel-like structures, positive for CD34, were observed ( b ). One vessel shows CD34-positive stain in the inner lining of a vascular-like structure (double arrow), whereas cells surrounding this structure only show blue H&E stain. Another microvessel-like CD34-positive structure reveals a sproutlike appearance (single arrow). c , d Quantifi cation of cells/high-power fi elds in sections stained with antibodies against the endothelial selective markers CD31 ( c ) and CD34 ( d ) in Tie2-tmTNF and wild-type mice.
than to an indirect autocrine-like effect by secretion of growth factors. Furthermore, neutralizing antibodies to either TNF-␣ (5 g/ml) or TNFRI (10 g/ml), but not isotype-matched IgG, signifi cantly reduced sprout formation in tmTNF-␣ cells, further supporting the direct angiogenic role for tmTNF-␣ ( fi g. 4 c).
Increased Vessel Growth in Tie2-tmTNF Mice
Next, we wanted to test in vivo whether endothelial cell activation mediated by stable transfection with TNF-␣ causes increased angiogenesis. In this assay, Matrigel solutions, incorporating growth factors (VEGF and FGF-2), were injected under the skin of Tie2-tmTNF transgenic and wild-type animals. After 2 weeks, neovascularization was quantifi ed in sections by immunostaining with CD31 and CD34, established markers for increased angiogenesis [37] [38] [39] [40] . As shown in fi gure 5 a and b, several cellular infi ltrates, CD34-positive structures, resembling blood vessels (arrows) can be seen in plugs from transgenic mice, whereas only few such structures are visible in wild-type animals. Quantifi cation of invading endothelial cells by use of the two markers CD31 and CD34 indicated signifi cantly higher neovascularization in Tie2-tmTNF transgenic versus wild-type mice ( fi g. 5 c, d).
Discussion
The present study demonstrates that continuous endothelial activation can lead to angiogenesis in vivo (Matrigel plug assay) and, in the complete absence of leukocytes, in vitro (sprout assay). Although recruitment of leukocytes is known to be a critical feature in pathologic instances of angiogenesis, which in turn is dependent on expression of endothelial adhesion molecules and/or on chemokines, here, we show that angiogenesis can occur directly with endothelial cell activation, apart from the complementary angiogenic effects of leukocytes. Importantly, this direct angiogenic effect of continuous endothelial cell activation also occurs in the absence of added growth factors in vitro.
Based on our and other studies, showing tmTNF-␣ to be upregulated in the highly angiogenic MethA fi brosarcoma of mice [18] as well as in neovessels of atherosclerotic plaques [41] , we hypothesized that tmTNF-␣ contributes to pathological angiogenesis. In this study, using the in vivo Matrigel model of angiogenesis, increased cellular infi ltrates positive for the endothelial markers CD31 and CD34 could be observed in plugs from transgenic mice versus wild-type animals, suggesting that TNF-␣ -elicited endothelial cell activation may contribute to angiogenesis in vivo. Although it is generally assumed that the endothelial marker CD31 is endothelial specifi c [37] , it can also be found on tumor-infi ltrating macrophages and lead to an overestimation of angiogenesis [42] . Therefore, we confi rmed our results using another marker, CD34, which is established in angiogenic vessels and absent on monocytes/macrophages [39] . Our fi nding that there are more CD34-positive than CD31-positive cells in the Matrigel plug assay of transgenic animals may be explained by higher numbers of CD34, Flk-1-and AC133-positive endothelial progenitor cells, which may not be fully differentiated into endothelial cells as reported previously [43] . In addition, this fi nding of more CD34 versus CD31 cells is unlikely to be explained by CD34-positive leukocytic precursor cells as we did not observe leukocyte infi ltration. Furthermore, both leukocytes and platelets can express CD31, so infi ltration does not account for the higher number of CD34-positive cells. This is important in light of the assumption that proinfl ammatory cells including macrophages modulate angiogenesis as growth factor-releasing cells [44] . However, this is not likely to be the cause of the stimulated angiogenesis in our assays since we have incorporated high concentrations of VEGF and bFGF into the Matrigel.
In further support of the hypothesis that the angiogenic activity observed within the Matrigel plug assay is mediated by a direct effect of tmTNF-␣ -expressing endothelial cells and not by leukocytes, we tested tmTNF-␣ -expressing endothelial cells in an in vitro assay for angiogenesis. It has previously been shown that this assay is suitable to study a variety of growth factors in vitro [45, 46] , and we demonstrated coherence of this assay with in vivo angiogenesis [32, 38] . When control endothelial cells were stimulated with VEGF, increased sprout formation was observed, similar to that which we previously demonstrated with other microvascular endothelial cells [32] .
In this study, tmTNF-␣ -expressing endothelial cells showed signifi cantly more sprout formation than control cells. This effect was comparable with the increase observed with an optimal concentration of VEGF. Interest- Previously, we have shown that in vitro tmTNF-␣ expression in human umbilical cord vein endothelial cells also caused an autonomous and continuous activation, exemplifi ed by persistent p38 mitogen-activated protein kinase and nuclear factor-B activation and by tissue factor and interleukin 6 production [18] . We also reported that Tie2-tmTNF (endothelial) expression in transgenic mice resulted in sustained expression of endothelial adhesion molecules for leukocytes in vivo [27] . In the present study, we demonstrate a stable and continuous surface expression of ICAM-1 and VCAM-1 on the surface of tmTNF-␣ -expressing murine endothelial cells, confi rming the earlier in vivo study on adhesion molecules [27] . Our results are in contrast to Canault et al. [47] who reported no signifi cant increase in ICAM-1 in mouse aortic endothelial cells. There are several possibilities which may explain the observed differences. Microvascular endothelial cells used in this study compared with macrovascular endothelial cells used by Canault et al. [47] could contribute to the differences, as could the difference in the transgenic models being used. Additionally, in our studies of in vitro and in vivo models, endogenous production of soluble TNF-␣ is possible, whereas Canault et al. [47] express the uncleavable tmTNF-␣ mutant in the absence of any soluble TNF-␣ using TNF-␣ gene-defi cient animals as 'genetic background'.
The elucidation of molecules and mechanisms underlying the continuous activated endothelium could provide new targets for drug development that spare the important infection-fi ghting activities of leukocytes and the physiologic benefi cial role of local TNF-␣ production, but terminate untoward continuous endothelial activation and its resultant contribution to pathologic infl ammation and angiogenesis. For instance, the ability of TNF-␣ to induce VCAM-1 and ICAM-1 may not only enhance emigration of leukocytes but also angiogenesis by yet another pathway. This requires proteolytic conversion of these cellular adhesion molecules to their soluble forms, which have been shown to synergize with TNF-␣ in both in vitro and in vivo models of angiogenesis [48, 49] . The supposition that selective signal transduction pathways, leading to expression of distinct vascular adhesion molecules, are involved in processes of chronic infl ammation is of clinical relevance, because it could lead to the development of more specifi c blockers of pathways in the chronic activation, which differ from the acute activation sequence. Such remedies could be designed based on the ability to interfere with specifi c signal transduction pathways, leading to selective adhesion molecule expression.
Recently, ROS were identifi ed as downstream mediators of angiogenic signaling by VEGF receptor 2/kinase insert domain receptor [50] . In this study, we found that oxidant production was signifi cantly increased in the tmTNF-␣ cells, indicating that with continuous activation there was also continuous oxidant production. The specifi c sources and mechanisms are yet to be thoroughly determined, but our data using apocynin, a NADPH oxidase inhibitor, suggest that increased superoxide generation with chronic activation by tmTNF is largely due to NADPH oxidase based on the 70-75% suppression of the increased superoxide generation by apocynin. However, this specifi c inhibition was not 100%, and thus, we have not absolutely ruled out smaller contributions from secondary NO synthase uncoupling due to superoxide/peroxynitrite-mediated tetrahydrobiopterin oxidation, cyclooxigenase activation, or mitochondrial changes. Nevertheless, the conclusion that NADPH oxidase is the primary source of increased oxidant production in tmTNF-expressing endothelial cells is consistent with acute activation of NADPH oxidase by exogenous, soluble TNF [34, 51, 52] , which is thought to be mediated by Rac1-associated assembly/activation of NADPH oxidase components [51, 52] . Moreover, our data are consistent with reports that increased oxidants can actually drive further upregulation of expression of NADPH oxidase components [unpubl. data; see also ref. 34] . Of note, the steady increase in cellular oxidants affects signaling, particularly in the different arms of the mitogen-activated protein kinase pathways, in such a way to potentially explain the chronic upregulation of the leukocyte adhesion molecules and the direct angiogenic effects that we observed [53] [54] [55] .
In conclusion, the present study specifi cally addresses the link between the infl ammation and blood vessel growth through the activated endothelium. Our hypothesis that the proinfl ammatory activated endothelium promotes angiogenesis in a manner that is both leukocyte dependent and leukocyte independent, and also in a growth factor-independent manner in vitro, is not only novel but also of biomedical signifi cance given the increasing number of reports on involvement of angiogenesis in diseases. Although much work remains to be accomplished, the putative link for continuous activated endothelium presented in this study could provide the impetus as an additional target for regulation of angiogenesis in pathological diseases.
